These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14106378)

  • 21. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of diabetes mellitus with sulfonylureas].
    DELBUE C
    Dia Med; 1960 Apr; 32():752-6. PubMed ID: 13815618
    [No Abstract]   [Full Text] [Related]  

  • 23. [The sulfonylureas in the treatment of the diabetic patient].
    RALLI EP
    Union Med Can; 1960 May; 89():618-26. PubMed ID: 14435982
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas.
    MEHNERT H
    Diabetes; 1962; 11(Suppl)():80-4. PubMed ID: 13934500
    [No Abstract]   [Full Text] [Related]  

  • 25. [Retention in the blood of chlorpropamide and of other sulfonylureas].
    PICCININI F
    Arch Ital Sci Farmacol; 1959 Oct; 9():540-3. PubMed ID: 14432714
    [No Abstract]   [Full Text] [Related]  

  • 26. Pancreatic action of the sulfonylureas.
    COLWELL AR; COLWELL JA
    J Lab Clin Med; 1959 Mar; 53(3):376-95. PubMed ID: 13631322
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of insulinase by sulfonylureas].
    STRASSLE R; PLETSCHER A
    Klin Wochenschr; 1957 Jul; 35(14):719-22. PubMed ID: 13515047
    [No Abstract]   [Full Text] [Related]  

  • 28. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetes mellitus and sulfonylureas. Results of a year of chlorpropamide treatment].
    DELBUE C
    Rev Argent Endocrinol Metab; 1959 Dec; 5():259-72. PubMed ID: 13721532
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of sulfonylureas on hepatic glucose release.
    KALDOR A; POGATSA G
    Diabetes; 1962; 11(Suppl)():16-8. PubMed ID: 13961901
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action of hypoglycemizing sulfonylureas on the phosphatase activity of the blood].
    da CRUZ
    C R Seances Soc Biol Fil; 1960; 154():229-31. PubMed ID: 13813101
    [No Abstract]   [Full Text] [Related]  

  • 32. [The significance of sulfonylureas and biguanide for the treatment of diabetes mellitus].
    MEHNERT H
    Chemotherapia (Basel); 1961; 2():262-82. PubMed ID: 13768997
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 34. THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS.
    GERZON K; KRUMKALNS EV; BRINDLE RL; MARSHALL FJ; ROOT MA
    J Med Chem; 1963 Nov; 6():760-3. PubMed ID: 14184942
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison in rabbits of hypoglycemia and B cell degranulation after various sulfonylureas.
    LAZARUS SS; VOLK BW
    Proc Soc Exp Biol Med; 1959 Oct; 102():67-70. PubMed ID: 14414809
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of sulfonylureas on fructose utilization in diabetes mellitus].
    BAIER H
    Klin Wochenschr; 1959 Apr; 37(7):399-401. PubMed ID: 13642776
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitory action of sulfonylureas on the arginase activity of guinea pig liver homogenates].
    TROPEANO L; DI STEFANO S; BELFIORE F
    Boll Soc Ital Biol Sper; 1960 May; 36():495-8. PubMed ID: 13839478
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis.
    NIKKILA EA; TEIR H
    Ann Med Exp Biol Fenn; 1960; 38():182-5. PubMed ID: 14427203
    [No Abstract]   [Full Text] [Related]  

  • 39. PREPARATION AND HYPOGLYCEMIC ACTIVITY OF SOME 3,5-DISUBSTITUTED HYDANTOINS.
    LOMBARDINO JG; GERBER CF
    J Med Chem; 1964 Jan; 7():97-101. PubMed ID: 14186035
    [No Abstract]   [Full Text] [Related]  

  • 40. NOVEL ORAL HYPOGLYCEMIC AGENTS. I. HEXAHYDROINDENO(1,2-C)PYRROLES AND INDANAMINES.
    LAHIRI SC; PATHAK B
    J Med Chem; 1965 Jan; 8():131-3. PubMed ID: 14289822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.